GALE 📈 Galenica Sante - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0360674466
GALE: Pharmaceuticals, Parapharmaceuticals, Consumer Health Products, Medication
Galenica Sante AG is a multifaceted healthcare service provider with operations in Switzerland and international markets, leveraging its extensive expertise to deliver comprehensive solutions. The company's business is structured into two primary segments: Products & Care, and Logistics & IT, each designed to cater to distinct aspects of the healthcare ecosystem. The Products & Care segment encompasses a network of pharmacies and partner pharmacies operating under renowned brands such as Amavita, Sun Store, and Coop Vitality, thereby ensuring a wide reach and accessibility to healthcare products and services. Additionally, this segment is involved in the provision of medication for patient treatment at home, underscoring the company's commitment to patient care beyond traditional pharmacy settings.
The Products & Care segment also plays a pivotal role in the launch and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products. By offering marketing and sales services to partners within the healthcare market, Galenica Sante AG facilitates a collaborative environment that fosters growth and innovation. This approach not only benefits the company but also contributes to the overall development of the healthcare sector. Furthermore, the segment's focus on consumer health products reflects the company's recognition of the evolving needs of healthcare consumers and its efforts to address these needs through a broad range of offerings.
The Logistics & IT segment of Galenica Sante AG provides a specialized suite of pre-wholesale services, including storage, distribution, and debt collection, tailored to meet the specific requirements of pharmaceutical and healthcare companies. This segment also develops and offers a master data system designed for the healthcare market, aiming to enhance data management and utilization across the sector. The development of management solutions for the healthcare market is another key area of focus, reflecting the company's commitment to leveraging technology and expertise to improve operational efficiencies and outcomes in healthcare. Internal IT services for the group and the publication of technical information on pharmaceutical products, both in print and electronic formats, further underscore the segment's role in supporting informed decision-making and comprehensive management solutions for pharmacies and other healthcare stakeholders.
With a history dating back to 1927, Galenica Sante AG is headquartered in Bern, Switzerland, and has established itself as a significant player in the healthcare service provision landscape. The company's web presence is maintained at https://www.galenica.com, offering a gateway to its services, initiatives, and corporate information. Listed with the ISIN CH0360674466 as a common stock, Galenica Sante AG falls under the GICS Sub Industry classification of Health Care Distributors, highlighting its core role in the distribution and provision of healthcare products and services. This classification also underscores the company's position within the broader healthcare industry, emphasizing its contribution to the supply chain and service delivery aspects of healthcare.
Additional Sources for GALE Stock
GALE Stock Overview
Market Cap in USD | 3,999m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception |
GALE Stock Ratings
Growth 5y | 45.4% |
Fundamental | 66.0% |
Dividend | 52.0% |
Rel. Strength Industry | 9.54 |
Analysts | - |
Fair Price Momentum | 74.44 CHF |
Fair Price DCF | 89.59 CHF |
GALE Dividends
Dividend Yield 12m | 1.44% |
Yield on Cost 5y | 1.88% |
Annual Growth 5y | 4.10% |
Payout Consistency | 93.4% |
GALE Growth Ratios
Growth Correlation 3m | 1.9% |
Growth Correlation 12m | 38.9% |
Growth Correlation 5y | 83.2% |
CAGR 5y | 5.43% |
CAGR/Mean DD 5y | 0.65 |
Sharpe Ratio 12m | 0.01 |
Alpha | -4.96 |
Beta | 0.22 |
Volatility | 13.56% |
Current Volume | 70.2k |
Average Volume 20d | 86.7k |
As of January 14, 2025, the stock is trading at CHF 76.35 with a total of 70,210 shares traded.
Over the past week, the price has changed by +0.86%, over one month by +1.87%, over three months by +1.19% and over the past year by +3.16%.
Yes, based on ValueRay Fundamental Analyses, Galenica Sante (SW:GALE) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.01 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GALE as of January 2025 is 74.44. This means that GALE is currently overvalued and has a potential downside of -2.5%.
Galenica Sante has no consensus analysts rating.
According to ValueRays Forecast Model, GALE Galenica Sante will be worth about 80.4 in January 2026. The stock is currently trading at 76.35. This means that the stock has a potential upside of +5.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 76.9 | 0.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 80.4 | 5.3% |